VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 9, 2009) - Allon Therapeutics Inc. (TSX:NPC) President and CEO Gordon McCauley will outline the Company’s progress on its 2009 clinical and corporate milestones at 11:30 a.m. EST today at the 11th annual BIO CEO and Investor Conference in New York City, and the Company announced the official USAN/INN name for its product candidate AL-108.
